Adverse events and oncotargeted kinase inhibitors /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Tridente, G. (Autor)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Amsterdam : Academic Press, [2017]
Temas:
Protein-tyrosine kinase > Inhibitors > Therapeutic use.
Protein-tyrosine kinase > Inhibitors.
Protein-Tyrosine Kinases > antagonists & inhibitors
Prot�eine-tyrosine kinase > Inhibiteurs.
Prot�eine-tyrosine kinase > Inhibiteurs > Emploi en th�erapeutique.
MEDICAL > Pharmacology.
Protein-tyrosine kinase > Inhibitors
Electronic books.
Internet Resources.
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Introduction
  • Kinases
  • Kinase inhibitors
  • Adverse events
  • Imantinib
  • Gefitinib
  • Erlotinib
  • Sorafenib
  • Sunitinib
  • Dasatinib
  • Lapatinib
  • Nilotinib
  • Pazopanib
  • Vandetanib
  • Vemurafenib
  • Crizotinib
  • Ruxolitinib
  • Axitinib
  • Bosutinib
  • Regorafenib
  • Cabozantinib
  • Ponatinib
  • Dabrafenib
  • Trametinib
  • Afatinib
  • Idelaisib
  • Ibrutinib
  • Overview
  • Conclusion and perspectives.

Ejemplares similares